Concepedia
Statistics
Publications
16
Citations
4.3K
H-Index
14
Active since
2004
Affiliations
Universitätsklinikum Erlangen(Current)
Hôpital Saint-André
Friedrich-Alexander-Universität Erlangen-Nürnberg
The Maria Sklodowska-Curie National Research Institute of Oncology
Charité - Universitätsmedizin Berlin
Eckhart Kaempgen is an author at Universitätsklinikum Erlangen specializing in oncology, medicine, and immunology.
Publications per year
2004–2017
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 3K citations
Medicine, Oncology, Pharmacology +11
Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
Steven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski et al. · Clinical Cancer Research · 2008 · 269 citations · Full text
Medicine, Immunology, Oncology +17
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
Stefan Rutkowski, Steven De Vleeschouwer, Eckhart Kaempgen et al. · British Journal of Cancer · 2004 · 171 citations · Full text
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Serge Leyvraz, Sophie Piperno‐Neumann, Stefan Suciu et al. · Annals of Oncology · 2014 · 147 citations · Full text
Medicine, Oncology, Surgery +17
Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors
Volker Lennerz, Elisa Gallerani, Cristiana Sessa et al. · Cancer Immunology Immunotherapy · 2014 · 126 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 16